[Transverse myelitis in systemic lupus erythematosus]

María Luisa Velloso Feijoo1, Francisco García Hernández, Celia Ocaña Medina

  • 1Unidad de Colagenosis. Servicio de Medicina Interna. Hospital Universitario Virgen del Rocío. Sevilla. España.

Reumatologia Clinica
|July 29, 2011
PubMed
Summary

Transverse myelitis (TM) affects 0.92% of systemic lupus erythematosus (SLE) patients. Antiphospholipid antibodies are common, and anticoagulation or antiplatelet therapy improves outcomes in these TM patients.